EDITORIAL SECTION

Articles

Top 5 Pharma Content Formats That Drive Engagement and Leads

The pharmaceutical business is experiencing a significant change in the way it informs the healthcare professionals decisionmakers and business partners Conventional means of promotion is no longer sufficient in a context whereby buyers do a lot of research before involving themselves with vendors Consequently pharma content marketing has turned out to be a vital instrument of establishing credibi...

Trustworthy AI in Drug Discovery: From Innovation to Regulatory Readiness

Artificial intelligence is entering a new phase in drug discovery After years of enthusiasm for predictive models generative chemistry and automated screening attention is shifting from what AI can generate to whether its outputs can be trusted

Greening the Pill: Pharmaceutical Companies Embrace Environmental Sustainability

In an age where global environmental sustainability is imperative various industries are reassessing their practices to diminish their ecological impact The pharmaceutical sector a crucial component of healthcare is no different This article explores the proactive steps taken by pharmaceutical companies to incorporate sustainability into manufacturing packaging and operations to lessen their envir...

Adaptive Trial Designs: Enhancing Speed and Decision-Making in Clinical Development

For decades the traditional clinical trial has followed a rigid script A protocol is written patients are enrolled the study runs to completion and only at the very end does the sponsor learn whether the investment paid off The model has served the industry well in terms of scientific rigour

Advanced 3D Cell Models: Moving from Promise to Practice in Drug Discovery

Over the past decade organoids spheroids and other advanced D cell models have transformed how researchers approach disease modelling and drug development Their ability to better reflect human biology than traditional D cultures has generated significant enthusiasm across pharmaceutical research yet widespread adoption remains a work in progress

Revolutionizing Health: The Future of Gene Editing and Genetic Engineering

In the realm of healthcare few advancements hold as much promise and controversy as gene editing and genetic engineering These technologies once confined to science fiction are now tangible tools

Techno Trends

Alume Biosciences Secures FDA Breakthrough Therapy Designation for Bevonescein

Alume Biosciences has received Breakthrough Therapy Designation BTD from the US Food and Drug Administration FDA for bevonescein an investigational fluorescent drug being developed to support realtime nerve visualisation during head and neck surgery in adults Bevonescein is an intravenous fluorescent peptidedye conjugate that binds to nerve tissue

Projects

SK pharmteco Plans More Than US$200 Million Investment in Small Molecule and Peptide Manufacturing

SK pharmteco is planning a fiveyear investment of more than US million to expand and modernise its pharmaceutical development and manufacturing operations in the United States The programme will strengthen capabilities for small molecules and peptides while supporting a more

Research Insights

One-month physicochemical stability study of idarubicin prepared in polyolefin-type bags for the treatment of hematological diseases

Idarubicine is a mainstay of the treatment strategy for hematological cancer The literature lacks stability data that comply with current preparation practices and recommendations for conducting stability studies

whitepaper

Post-Translational Modifications in Drug Discovery: From Molecular Regulation to Clinical Impact

For decades the central dogma of molecular biology has anchored our understanding of cellular function DNA to RNA to protein But this linear view is incomplete A growing body of evidence shows that much of biologys